NCT01408563 · OUTCOME

Immune Reconstitution - Median CD4 Count at 12 Months

Reduced Intensity Double Umbilical Cord Blood Transplantation · Source last updated 2019-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEDIAN
Unit: cells/mm3
Interval / dispersion: Full Range
Time frame: 1 Year

Analysis population: CD4 counts were only available for 11 participants at the 12 months time point

Groups in this outcome

Fludarabine/Melphalan/TBI

All patients receive same therapy Fludarabine: 30 mg/m2/day IV x 6 days Melphalan: 100 mg/m2/day IV x 1 day Total Body Radiation: 200 cGy on Day 0 Cord Blood: 2 cord blood units IV

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Fludarabine/Melphalan/TBI	11

Reported measurements

Source class 1

Values in cells/mm3 · Interval/dispersion: Full Range
Group	Value	Spread	Lower	Upper	Comment
Fludarabine/Melphalan/TBI	362.4	Not reported	125.3	1157.8	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
125.3
upper Limit
1157.8
value
362.4

denoms

counts
group Id
OG000
value
11
units
Participants

dispersion Type

Full Range

groups

description
All patients receive same therapy Fludarabine: 30 mg/m2/day IV x 6 days Melphalan: 100 mg/m2/day IV x 1 day Total Body Radiation: 200 cGy on Day 0 Cord Blood: 2 cord blood units IV
id
OG000
title
Fludarabine/Melphalan/TBI

param Type

MEDIAN

population Description

CD4 counts were only available for 11 participants at the 12 months time point

reporting Status

POSTED

time Frame

1 Year

title

Immune Reconstitution - Median CD4 Count at 12 Months

type

SECONDARY

unit Of Measure

cells/mm3

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice